CIP2A has been identified as a prognostic marker in non-small cell lung cancer, as its expression was higher in lung tumor tissue compared to corresponding normal tissue [19], and high levels of the protein in tumor samples were associated with reduced overall survival [19,20,21]. Here, CIP2A is linked to non-small cell lung carcinoma.